Get the Stockscreener App
2.15
2.71%
-0.06
Overview
News
Price History
Option Chain
Financials
Why SAVA Down?
Discussions
Forecast
Stock Split
Dividend History
Cassava Sciences Inc stock is traded at $2.15, with a volume of 480.74K.
It is down -2.71% in the last 24 hours and down -6.11% over the past month.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.
See More
Previous Close:
$2.21
Open:
$2.21
24h Volume:
480.74K
Relative Volume:
0.57
Market Cap:
$103.86M
Revenue:
-
Net Income/Loss:
$-97.22M
P/E Ratio:
-1.558
EPS:
-1.38
Net Cash Flow:
$-82.44M
1W Performance:
-9.66%
1M Performance:
-6.11%
6M Performance:
-19.78%
1Y Performance:
-92.76%
1-Day Range:
$2.12
$2.22
1-Week Range:
$2.12
$2.39
52-Week Range:
$1.15
$33.98
Cassava Sciences Inc Stock (SAVA) Company Profile
Name
Cassava Sciences Inc
Sector
Industry
Phone
512-501-2444
Address
6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN, TX
Compare SAVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SAVA
Cassava Sciences Inc
|
2.15 | 109.66M | 0 | -97.22M | -82.44M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Cassava Sciences Inc Stock (SAVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-26-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-08-24 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Jul-01-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Nov-16-22 | Downgrade | B. Riley Securities | Buy → Neutral |
| Jul-15-21 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-07-21 | Reiterated | Maxim Group | Buy |
| Apr-27-21 | Initiated | B. Riley Securities | Buy |
| Feb-16-21 | Reiterated | H.C. Wainwright | Buy |
| Oct-23-20 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-23-20 | Upgrade | H.C. Wainwright | Neutral → Buy |
| May-18-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| May-15-20 | Downgrade | Maxim Group | Buy → Hold |
| Jan-10-20 | Reiterated | Maxim Group | Buy |
View All
Cassava Sciences Inc Stock (SAVA) Latest News
Analyzing Cassava Sciences Inc. Equity Warrant with risk reward ratio chartsJuly 2025 Weekly Recap & Daily Profit Focused Stock Screening - Newser
Can machine learning forecast Cassava Sciences Inc. recoveryJuly 2025 Action & Expert Curated Trade Setups - Newser
Historical volatility pattern of Cassava Sciences Inc. visualizedMarket Growth Summary & AI Forecast for Swing Trade Picks - Newser
Visual analytics tools that track Cassava Sciences Inc. performanceCEO Change & Verified Technical Signals - Newser
How to track smart money flows in Cassava Sciences Inc.2025 Market Sentiment & Daily Price Action Insights - Newser
Cassava Sciences Inc. stock trendline breakdownMarket Trend Summary & Reliable Intraday Trade Plans - Newser
How high can Cassava Sciences Inc. stock goWeekly Gains Summary & Fast Exit and Entry Trade Guides - Newser
Is Cassava Sciences Inc. backed by strong institutional buying2025 Technical Overview & Weekly Consistent Profit Watchlists - khodrobank.com
Volume spikes in Cassava Sciences Inc. stock – what they meanAnalyst Downgrade & Risk Controlled Daily Plans - Newser
What to expect from Cassava Sciences Inc. Equity Warrant in the next 30 daysMarket Trend Summary & High Conviction Buy Zone Alerts - Newser
What’s next for Cassava Sciences Inc. Equity Warrant stock price2025 Year in Review & Reliable Volume Spike Trade Alerts - Newser
Measuring Cassava Sciences Inc. Equity Warrant’s beta against major indicesTrade Risk Summary & Technical Pattern Alert System - Newser
Will Cassava Sciences Inc. Equity Warrant stock recover after recent drop2025 Investor Takeaways & Daily Technical Stock Forecast Reports - Newser
Will Cassava Sciences Inc. outperform small cap indexesJuly 2025 Final Week & Short-Term Trading Opportunity Alerts - khodrobank.com
Price momentum metrics for Cassava Sciences Inc. explainedJuly 2025 Levels & Low Risk High Reward Trade Ideas - Newser
Visual analytics tools that track Cassava Sciences Inc. Equity Warrant performanceJuly 2025 Decliners & Accurate Technical Buy Alerts - Newser
Custom watchlist performance reports with Cassava Sciences Inc.Market Activity Recap & Free Daily Entry Point Trade Alerts - Newser
Using AI based signals to follow Cassava Sciences Inc. Equity WarrantQuarterly Portfolio Review & Advanced Swing Trade Entry Plans - Newser
Short Term Trend Reversal in Cassava Sciences Inc. Equity Warrant PossibleJuly 2025 Recap & Fast Exit and Entry Strategy Plans - beatles.ru
Using portfolio simulators with Cassava Sciences Inc. included2025 Big Picture & High Conviction Buy Zone Picks - Newser
How to recover losses in Cassava Sciences Inc. Equity Warrant stockJuly 2025 Volume & Capital Efficient Trading Techniques - Newser
Will breakout in Cassava Sciences Inc. lead to full recoveryPortfolio Profit Report & Breakout Confirmation Alerts - Newser
Is Cassava Sciences Inc. Equity Warrant stock risky to hold nowJuly 2025 Snapshot & Fast Gain Stock Trading Tips - khodrobank.com
Will Cassava Sciences Inc. benefit from macro trendsJuly 2025 Outlook & AI Based Buy/Sell Signal Reports - Newser
Can Cassava Sciences Inc. recover in the next quarterTrade Risk Report & Free Expert Approved Momentum Trade Ideas - Newser
How sensitive is Cassava Sciences Inc. to inflation2025 Market WrapUp & AI Driven Stock Movement Reports - khodrobank.com
Tick level data insight on Cassava Sciences Inc. volatilityJuly 2025 EndofMonth & Risk Controlled Daily Trade Plans - Newser
Key resistance and support levels for Cassava Sciences Inc. Equity WarrantMarket Risk Summary & Long-Term Capital Growth Ideas - Newser
Applying big data sentiment scoring on Cassava Sciences Inc. Equity WarrantWeekly Risk Report & AI Powered Market Entry Strategies - Newser
Using Ichimoku Cloud for Cassava Sciences Inc. technicals2025 Trade Ideas & Scalable Portfolio Growth Ideas - Newser
How moving averages guide Cassava Sciences Inc. tradingWeekly Market Report & AI Enhanced Trade Execution Alerts - Newser
Will Cassava Sciences Inc. Equity Warrant price bounce be sustainableJuly 2025 Decliners & Target Return Focused Picks - Newser
Analyzing net buyer seller activity in Cassava Sciences Inc. Equity Warrant2025 Trade Ideas & Weekly Top Performers Watchlists - Newser
Why is Cassava Sciences Inc. Equity Warrant stock going downWeekly Trade Review & Risk Controlled Swing Alerts - khodrobank.com
NinjaOne, Astrotech, and Recurly among Austin companies adding key leadership roles - The Business Journals
News impact scoring models applied to Cassava Sciences Inc.July 2025 Setups & Fast Entry High Yield Tips - Newser
Evaluating Cassava Sciences Inc. with trendline analysisWeekly Stock Summary & Community Consensus Stock Picks - Newser
Is Cassava Sciences Inc. Equity Warrant still worth holding after the dipJuly 2025 Recap & Capital Efficient Trade Techniques - Newser
Combining price and volume data for Cassava Sciences Inc. Equity WarrantWeekly Profit Analysis & Reliable Breakout Stock Forecasts - Newser
Why is Cassava Sciences Inc. stock going upJuly 2025 Review & Growth Focused Stock Reports - khodrobank.com
Using Python tools to backtest Cassava Sciences Inc. Equity Warrant strategies2025 Growth vs Value & Weekly Market Pulse Updates - Newser
Detecting support and resistance levels for Cassava Sciences Inc. Equity WarrantWeekly Trade Analysis & Verified Momentum Stock Alerts - Newser
How cyclical is Cassava Sciences Inc. Equity Warrant’s revenue streamJuly 2025 Drop Watch & Low Risk Profit Maximizing Plans - khodrobank.com
Does Cassava Sciences Inc. Equity Warrant meet Warren Buffett’s criteriaQuarterly Trade Report & Technical Confirmation Trade Alerts - khodrobank.com
How to integrate Cassava Sciences Inc. into portfolio analysis tools2025 Institutional Moves & Fast Moving Market Watchlists - Newser
Real time breakdown of Cassava Sciences Inc. Equity Warrant stock performanceSell Signal & AI Enhanced Trading Signals - Newser
Cassava Sciences Inc Stock (SAVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cassava Sciences Inc Stock (SAVA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Schoen Eric | Chief Financial Officer |
Nov 29 '24 |
Option Exercise |
1.18 |
50,000 |
59,000 |
71,300 |
| Schoen Eric | Chief Financial Officer |
Nov 29 '24 |
Sale |
3.86 |
59,800 |
230,828 |
11,500 |
| Schoen Eric | Chief Financial Officer |
Nov 29 '24 |
Sale |
3.82 |
2,000 |
7,640 |
0 |
1.75%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):